NCT02415738

Brief Summary

Hypoxemia may be refractory to protective ventilation during the acute respiratory distress syndrome (ARDS), justifying the use of other therapies that improved oxygenation and decreased mortality, including prone position (PP). During ARDS, the majority of patients are responders to PP with increased PaO2 due to homogenization of the ventilation-perfusion ratio. Despite changes in intra-thoracic and intra-abdominal pressure, hemodynamic parameters are not changed. Besides the fact that the PP improves systemic oxygenation is it the same on cerebral oxygenation? No study has investigated the cerebral oxygenation during PP in patients with ARDS. The cerebral oxygenation may be altered due to the position of the patient and high levels of positive end-expiratory pressure. This decrease oxygenation may be responsible for cognitive impairment when patients awake. NIRS (Near Infrared Spectroscopy) is a noninvasive tool, capable of delivering information on cerebral oxidative metabolism and its hemodynamic status. It can be used routinely for the management of resuscitation in Intensive Care Unit (ICU) patients. This study is to investigate cerebral oxygenation during prone position in the investigators' patients of ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 9, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 14, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

March 13, 2017

Status Verified

March 1, 2017

Enrollment Period

1.8 years

First QC Date

April 9, 2015

Last Update Submit

March 9, 2017

Conditions

Keywords

Near infrared spectroscopyCerebral oxygenationAcute respiratory distress syndromProne positioning

Outcome Measures

Primary Outcomes (1)

  • Brain oxygenation

    18 hours

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ARDS

You may qualify if:

  • Patient with moderate and severe ARDS from 12h, defined by:
  • Acute onset of respiratory failure
  • Parenchymal opacities Bilateral not fully explained by pleural effusion, nodules, masses or atelectasis
  • Unexplained cardiac or vascular insufficiency filling respiratory distress
  • PaO2 / FiO2 ≤ 200 with FiO2\> 60% and PEEP ≥ 5cmH2O
  • Need for invasive mechanical ventilation
  • Hemoglobin\> 8 g / dL
  • Ramsay score 6 sedated with midazolam and Sufentanyl and neuromuscular blockade by Atracurium.

You may not qualify if:

  • Participation in another study requiring specific management of ARDS;
  • Against-indication for prone position:
  • Burns or wounds in the face, chest and abdominal wall
  • Recent thoraco-abdominal surgical incision
  • Spinal instability, pelvic fracture
  • State of uncontrolled shock
  • intracranial hypertension
  • Alteration of the NIRS signal:
  • Brain damage: extra-dural hematoma, subdural hematoma, pneumocephalus, ischemic stroke, subarachnoid hemorrhage, intracerebral expansive process
  • Skin lesions at the electrodes
  • Jaundice bilirubin
  • ECMO
  • Pregnant or breastfeeding women
  • Age less than 18 years
  • Opposition patient, a family member, person of trust or the legal representative for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHBA

Vannes, 56 000, France

Location

MeSH Terms

Interventions

Prone Position

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2015

First Posted

April 14, 2015

Study Start

April 1, 2015

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

March 13, 2017

Record last verified: 2017-03

Locations